Indivior PLC (LON:INDV)

Market Cap	1.05B
Revenue (ttm)	905.57M
Net Income (ttm)	-47.99M
Shares Out	124.77M
EPS (ttm)	-0.37
PE Ratio	n/a
Forward PE	8.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	479,295
Average Volume	297,508
Open	829.42
Previous Close	841.00
Day's Range	790.50 - 838.50
52-Week Range	548.71 - 1,485.00
Beta	0.34
RSI	58.81
Earnings Date	Apr 25, 2025

About Indivior

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX T...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 1,051
• Stock Exchange: London Stock Exchange
• Ticker Symbol: INDV

Financial Performance

Financial numbers in USD